Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Isolated Imunohistochemistry-positive Cells Without Morphologic Characteristics of Melanoma Should Not Result in Designation as a Positive Sentinel Lymph Node According to the AJCC 8th Edition Staging System

Scolyer, Richard A. MD, FRCPA, FRCPath*,†,‡; Gershenwald, Jeffrey E. MD, FACS§; Thompson, John F. MD, FRACS, FACS*,†,‡

The American Journal of Surgical Pathology: July 12, 2019 - Volume Publish Ahead of Print - Issue - p
doi: 10.1097/PAS.0000000000001326
Letter to the Editor: PDF Only

*Melanoma Institute Australia

Central Clinical School, The University of Sydney, Sydney

Royal Prince Alfred Hospital Camperdown, NSW, Australia

§Departments of Surgical Oncology and Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston TX

Conflicts of Interest and Source of Funding: J.F.T. has been a member of advisory boards for and received honoraria/travel support from GlaxoSmithKline, Merck Sharp Dohme, Bristol Myers Squibb and Provectus Inc., all unrelated to the content of this work. J.F.T. is supported by the Melanoma Foundation of the University of Sydney. J.E.G. has served in a consultant or advisory role for Merck, Bristol-Myers Squibb, Novartis, Syndax, Neracare, and Castle Biosciences, unrelated to the content of this work. R.A.S. has served on advisory boards for Merck Sharp Dohme, Novartis, Myriad and NeraCare, unrelated to the content of this work. R.A.S. is supported by the National Health and Medical Research Council.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.